All In MedTech

FDA Clearance Tracker · P140033-S096

Assurity MRI, Endurity MRI family of Pacemakers

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jun 17, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jun 17, 2025

Approved

Time to decision

90 days

Received Mar 19, 2025. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P140033-S096
Device name
Assurity MRI, Endurity MRI family of Pacemakers
Applicant location
Sylmar, CA
Received
Mar 19, 2025
Decided
Jun 17, 2025
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P140033

Device type

Device class
Class III

Every decision under product code LWP

FDA's approval statement

As written in FDA's record.

approval for the AVEIR AR 2 LSP203A Leadless Pacemaker (LP), including updates to LP design, labeling, and Merlin PCS Programmer Software 3330 v28.5.x.

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.